|
References Abraham, D., Krenn, K., Seebacher, G., Paulus, P., Klepetko, W. & Aharinejad, S. (2004). Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts. Ann Thorac Surg 77, 1751-5. AbuBakar, S., Chan, Y. F. & Lam, S. K. (2000). Outbreaks of enterovirus 71 infection. N Engl J Med 342, 355-6. Amin, M. A., Haas, C. S., Zhu, K., Mansfield, P. J., Kim, M. J., Lackowski, N. P. & Koch, A. E. (2006). Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 107, 2252-61. Andrikopoulou, E., Zhang, X., Sebastian, R., Marti, G., Liu, L., Milner, S. M. & Harmon, J. W. Current Insights into the role of HIF-1 in cutaneous wound healing. Curr Mol Med 11, 218-35. Arndt, U., Wennemuth, G., Barth, P., Nain, M., Al-Abed, Y., Meinhardt, A., Gemsa, D. & Bacher, M. (2002). Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J Virol 76, 9298-306. Bacher, M., Eickmann, M., Schrader, J., Gemsa, D. & Heiske, A. (2002). Human cytomegalovirus-mediated induction of MIF in fibroblasts. Virology 299, 32-7. Bacher, M., Metz, C. N., Calandra, T., Mayer, K., Chesney, J., Lohoff, M., Gemsa, D., Donnelly, T. & Bucala, R. (1996). An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 93, 7849-54. Baugh, J. A., Gantier, M., Li, L., Byrne, A., Buckley, A. & Donnelly, S. C. (2006). Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun 347, 895-903. Bernhagen, J., Calandra, T. & Bucala, R. (1998). Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med (Berl) 76, 151-61. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A. & Bucala, R. (1993). MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-9. Borde, C., Barnay-Verdier, S., Gaillard, C., Hocini, H., Marechal, V. & Gozlan, J. Stepwise release of biologically active HMGB1 during HSV-2 infection. PLoS One 6, e16145. Bruick, R. K. & McKnight, S. L. (2001). Building better vasculature. Genes Dev 15, 2497-502. Burger-Kentischer, A., Finkelmeier, D., Thiele, M., Schmucker, J., Geiger, G., Tovar, G. E. & Bernhagen, J. (2005). Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif. FEBS Lett 579, 1693-701. Bustin, M. (1999). Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19, 5237-46. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A. & Bucala, R. (1995). MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71. Calandra, T. & Roger, T. (2003). Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3, 791-800. Chan, L. G., Parashar, U. D., Lye, M. S., Ong, F. G., Zaki, S. R., Alexander, J. P., Ho, K. K., Han, L. L., Pallansch, M. A., Suleiman, A. B., Jegathesan, M. & Anderson, L. J. (2000). Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 31, 678-83. Chang, L. Y. (2008). Enterovirus 71 in Taiwan. Pediatr Neonatol 49, 103-12. Chavez, J. C., Baranova, O., Lin, J. & Pichiule, P. (2006). The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26, 9471-81. Chen, K. T., Chang, H. L., Wang, S. T., Cheng, Y. T. & Yang, J. Y. (2007). Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics 120, e244-52. Chen, L. C., Lei, H. Y., Liu, C. C., Shiesh, S. C., Chen, S. H., Liu, H. S., Lin, Y. S., Wang, S. T., Shyu, H. W. & Yeh, T. M. (2006a). Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 74, 142-7. Chen, L. C., Shyu, H. W., Chen, S. H., Lei, H. Y., Yu, C. K. & Yeh, T. M. (2006b). Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol 78, 780-6. de Mendonca-Filho, H. T., Gomes, R. V., de Almeida Campos, L. A., Tura, B., Nunes, E. M., Gomes, R., Bozza, F., Bozza, P. T. & Castro-Faria-Neto, H. C. (2004). Circulating levels of macrophage migration inhibitory factor are associated with mild pulmonary dysfunction after cardiopulmonary bypass. Shock 22, 533-7. Degryse, B., Bonaldi, T., Scaffidi, P., Muller, S., Resnati, M., Sanvito, F., Arrigoni, G. & Bianchi, M. E. (2001). The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152, 1197-206. Dodd, D. A., Giddings, T. H., Jr. & Kirkegaard, K. (2001). Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J Virol 75, 8158-65. Donnelly, S. C., Haslett, C., Reid, P. T., Grant, I. S., Wallace, W. A., Metz, C. N., Bruce, L. J. & Bucala, R. (1997). Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3, 320-3. Emonts, M., Sweep, F. C., Grebenchtchikov, N., Geurts-Moespot, A., Knaup, M., Chanson, A. L., Erard, V., Renner, P., Hermans, P. W., Hazelzet, J. A. & Calandra, T. (2007). Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis 44, 1321-8. Froidevaux, C., Roger, T., Martin, C., Glauser, M. P. & Calandra, T. (2001). Macrophage migration inhibitory factor and innate immune responses to bacterial infections. Crit Care Med 29, S13-5. Fukushima, T., Nishihira, J., Yoshiki, T., Iwabuchi, K., Iwabuchi, C., Yamasaki, Y., Kondo, M., Sun, B., Sato, Y. & Todo, S. (2005). Evidence of dual function of macrophage migration inhibitory factor relevant to tumor progression and regression. Int J Mol Med 16, 119-26. Germain, S., Monnot, C., Muller, L. & Eichmann, A. Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding. Curr Opin Hematol 17, 245-51. Gu, Y. Z., Moran, S. M., Hogenesch, J. B., Wartman, L. & Bradfield, C. A. (1998). Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr 7, 205-13. Harada, H. & Grant, S. (2003). Apoptosis regulators. Rev Clin Exp Hematol 7, 117-38. Herder, C., Kolb, H., Koenig, W., Haastert, B., Muller-Scholze, S., Rathmann, W., Holle, R., Thorand, B. & Wichmann, H. E. (2006). Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 29, 368-71. Ho, H. Y., Cheng, M. L., Weng, S. F., Leu, Y. L. & Chiu, D. T. (2009). Antiviral effect of epigallocatechin gallate on enterovirus 71. J Agric Food Chem 57, 6140-7. Ho, M., Chen, E. R., Hsu, K. H., Twu, S. J., Chen, K. T., Tsai, S. F., Wang, J. R. & Shih, S. R. (1999). An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341, 929-35. Huang, S. W., Lee, Y. P., Hung, Y. T., Lin, C. H., Chuang, J. I., Lei, H. Y., Su, I. J. & Yu, C. K. Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice. Respir Res 12, 147. Irwin, D. C., McCord, J. M., Nozik-Grayck, E., Beckly, G., Foreman, B., Sullivan, T., White, M., T. Crossno J, J., Bailey, D., Flores, S. C., Majka, S., Klemm, D. & van Patot, M. C. (2009). A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic Biol Med 47, 55-61. Jewell, U. R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R. H. & Gassmann, M. (2001). Induction of HIF-1alpha in response to hypoxia is instantaneous. Faseb J 15, 1312-4. Jiang, B. H., Zheng, J. Z., Leung, S. W., Roe, R. & Semenza, G. L. (1997). Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 272, 19253-60. Kelly, B. D., Hackett, S. F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P. A. & Semenza, G. L. (2003). Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93, 1074-81. Krysko, D. V., Vanden Berghe, T., D'Herde, K. & Vandenabeele, P. (2008). Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 44, 205-21. Lee, T. C., Guo, H. R., Su, H. J., Yang, Y. C., Chang, H. L. & Chen, K. T. (2009). Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J 28, 904-10. Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A. & Bucala, R. (2003). MIF signal transduction initiated by binding to CD74. J Exp Med 197, 1467-76. Li, C. C., Yang, M. Y., Chen, R. F., Lin, T. Y., Tsao, K. C., Ning, H. C., Liu, H. C., Lin, S. F., Yeh, W. T., Chu, Y. T. & Yang, K. D. (2002). Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scand J Infect Dis 34, 104-9. Liang, C. C., Sun, M. J., Lei, H. Y., Chen, S. H., Yu, C. K., Liu, C. C., Wang, J. R. & Yeh, T. M. (2004). Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. J Med Virol 74, 597-603. Lien-Cheng, C. & Trai-Ming, Y. (2009). Enterovirus 71 Infection of Human Immune Cells Induces the Production of Proinflammatory Cytokines. Journal of Biomedical & Laboratory Sciences 21, 82-90. Lin, T. Y., Chang, L. Y., Hsia, S. H., Huang, Y. C., Chiu, C. H., Hsueh, C., Shih, S. R., Liu, C. C. & Wu, M. H. (2002a). The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 34 Suppl 2, S52-7. Lin, T. Y., Chang, L. Y., Huang, Y. C., Hsu, K. H., Chiu, C. H. & Yang, K. D. (2002b). Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr 91, 632-5. Lin, T. Y., Hsia, S. H., Huang, Y. C., Wu, C. T. & Chang, L. Y. (2003). Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis 36, 269-74. Liu, A., Jin, H., Dirsch, O., Deng, M., Huang, H., Brocker-Preuss, M. & Dahmen, U. Release of danger signals during ischemic storage of the liver: a potential marker of organ damage? Mediators Inflamm 2010, 436145. Liu, C. C., Tseng, H. W., Wang, S. M., Wang, J. R. & Su, I. J. (2000). An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J Clin Virol 17, 23-30. Lu, J., He, Y. Q., Yi, L. N., Zan, H., Kung, H. F. & He, M. L. Viral kinetics of enterovirus 71 in human abdomyosarcoma cells. World J Gastroenterol 17, 4135-42. Lue, H., Kleemann, R., Calandra, T., Roger, T. & Bernhagen, J. (2002). Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4, 449-60. Lukashev, A. N., Koroleva, G. A., Lashkevich, V. A. & Mikhailov, M. I. (2009). [Enterovirus 71: epidemiology and diagnostics]. In Zh Mikrobiol Epidemiol Immunobiol, pp. 110-6. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A. & Poellinger, L. (2001). Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550-4. Makino, Y., Kanopka, A., Wilson, W. J., Tanaka, H. & Poellinger, L. (2002). Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J Biol Chem 277, 32405-8. Martin, T. R. (2000). MIF mediation of sepsis. Nat Med 6, 140-1. Mitchell, R. A. (2004). Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16, 13-9. Morand, E. F., Leech, M. & Bernhagen, J. (2006). MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5, 399-410. Naldini, A., Carraro, F., Fleischmann, W. R., Jr. & Bocci, V. (1993). Hypoxia enhances the antiviral activity of interferons. J Interferon Res 13, 127-32. Nishino, T., Bernhagen, J., Shiiki, H., Calandra, T., Dohi, K. & Bucala, R. (1995). Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med 1, 781-8. Nolan, M. A., Craig, M. E., Lahra, M. M., Rawlinson, W. D., Prager, P. C., Williams, G. D., Bye, A. M. & Andrews, P. I. (2003). Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 60, 1651-6. Pakozdi, A., Amin, M. A., Haas, C. S., Martinez, R. J., Haines, G. K., 3rd, Santos, L. L., Morand, E. F., David, J. R. & Koch, A. E. (2006). Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther 8, R132. Park, S. K., Dadak, A. M., Haase, V. H., Fontana, L., Giaccia, A. J. & Johnson, R. S. (2003). Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 23, 4959-71. Parrish, W. & Ulloa, L. (2007). High-mobility group box-1 isoforms as potential therapeutic targets in sepsis. Methods Mol Biol 361, 145-62. Payen, D., Faivre, V., Lukaszewicz, A. C., Villa, F. & Goldberg, P. (2009). Expression of monocyte human leukocyte antigen-DR in relation with sepsis severity and plasma mediators. Minerva Anestesiol 75, 484-93. Pina-Oviedo, S., Khalili, K. & Del Valle, L. (2009). Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy. Acta Neuropathol 118, 235-47. Porebska, I., Wyrodek, E., Kosacka, M., Adamiak, J., Jankowska, R. & Harlozinska-Szmyrka, A. (2006). Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. In Vivo 20, 599-604. Powis, G. & Kirkpatrick, L. (2004). Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther 3, 647-54. Prochazkova, J., Lichnovsky, V., Kylarova, D., Erdosova, B. & Vranka, P. (2004). Involvement of p53 and Bcl-2 family proteins in regulating programmed cell death and proliferation in human embryogenesis. Gen Physiol Biophys 23, 209-29. Ren, Y., Law, S., Huang, X., Lee, P. Y., Bacher, M., Srivastava, G. & Wong, J. (2005). Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 242, 55-63. Roger, T., David, J., Glauser, M. P. & Calandra, T. (2001). MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920-4. Scaffidi, P., Misteli, T. & Bianchi, M. E. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-5. Schmidt, N. J., Lennette, E. H. & Ho, H. H. (1974). An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129, 304-9. Semenza, G. L. (2000). Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 106, 809-12. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721-32. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. & Dvorak, H. F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-5. Shabnam, M. S., Srinivasan, R., Wali, A., Majumdar, S., Joshi, K. & Behera, D. (2004). Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Lung Cancer 45, 181-8. Shekhar, K., Lye, M. S., Norlijah, O., Ong, F., Looi, L. M., Khuzaiah, R., Marzuki, I., Hussein, I., Wong, S. L., Mohan, J., Sinniah, M. & Abu Bakar, S. (2005). Deaths in children during an outbreak of hand, foot and mouth disease in Peninsular Malaysia--clinical and pathological characteristics. Med J Malaysia 60, 297-304. Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., Noble, P., Knudson, W. & Bucala, R. (2006). CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595-606. Shih, S. R., Ho, M. S., Lin, K. H., Wu, S. L., Chen, Y. T., Wu, C. N., Lin, T. Y., Chang, L. Y., Tsao, K. C., Ning, H. C., Chang, P. Y., Jung, S. M., Hsueh, C. & Chang, K. S. (2000). Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res 68, 127-36. Shimizu, T., Nishihira, J., Watanabe, H., Abe, R., Honda, A., Ishibashi, T. & Shimizu, H. (2004). Macrophage migration inhibitory factor is induced by thrombin and factor Xa in endothelial cells. J Biol Chem 279, 13729-37. Smith, T. G., Robbins, P. A. & Ratcliffe, P. J. (2008). The human side of hypoxia-inducible factor. Br J Haematol 141, 325-34. Sowter, H. M., Raval, R. R., Moore, J. W., Ratcliffe, P. J. & Harris, A. L. (2003). Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63, 6130-4. Suzuki, T., Ogata, A., Tashiro, K., Nagashima, K., Tamura, M., Yasui, K. & Nishihira, J. (2000). Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain. Biochim Biophys Acta 1517, 100-6. Takahashi, M., Nishihira, J., Shimpo, M., Mizue, Y., Ueno, S., Mano, H., Kobayashi, E., Ikeda, U. & Shimada, K. (2001). Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res 52, 438-45. Tee, K. K., Takebe, Y. & Kamarulzaman, A. (2009). Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect Dis 13, 307-18. Tian, H., McKnight, S. L. & Russell, D. W. (1997). Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11, 72-82. Tran, C. B., Nguyen, H. T., Phan, H. T., Tran, N. V., Wills, B., Farrar, J., Santangelo, J. D. & Simmons, C. P. The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam. PLoS One 6, e21116. Tung, W. H., Hsieh, H. L., Lee, I. T. & Yang, C. M. Enterovirus 71 induces integrin beta1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: role of HO-1/CO in viral replication. J Cell Physiol 226, 3316-29. Ushio-Fukai, M. & Nakamura, Y. (2008). Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266, 37-52. Verjans, E., Noetzel, E., Bektas, N., Schutz, A. K., Lue, H., Lennartz, B., Hartmann, A., Dahl, E. & Bernhagen, J. (2009). Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC Cancer 9, 230. Verschuren, L., Lindeman, J. H., van Bockel, J. H., Abdul-Hussien, H., Kooistra, T. & Kleemann, R. (2005). Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms. Antioxid Redox Signal 7, 1195-202. Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92, 5510-4. Wang, H., Ward, M. F., Fan, X. G., Sama, A. E. & Li, W. (2006a). Potential role of high mobility group box 1 in viral infectious diseases. Viral Immunol 19, 3-9. Wang, S. M., Lei, H. Y., Huang, K. J., Wu, J. M., Wang, J. R., Yu, C. K., Su, I. J. & Liu, C. C. (2003). Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188, 564-70. Wang, S. M., Lei, H. Y., Huang, M. C., Su, L. Y., Lin, H. C., Yu, C. K., Wang, J. L. & Liu, C. C. (2006b). Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol 37, 47-52. Wang, S. M., Lei, H. Y., Yu, C. K., Wang, J. R., Su, I. J. & Liu, C. C. (2008). Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis 198, 1002-6. Wang, S. M. & Liu, C. C. (2009). Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther 7, 735-42. Watanabe, H., Shimizu, T., Nishihira, J., Abe, R., Nakayama, T., Taniguchi, M., Sabe, H., Ishibashi, T. & Shimizu, H. (2004). Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J Biol Chem 279, 1676-83. Weiser, W. Y., Temple, P. A., Witek-Giannotti, J. S., Remold, H. G., Clark, S. C. & David, J. R. (1989). Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A 86, 7522-6. Welford, S. M., Bedogni, B., Gradin, K., Poellinger, L., Broome Powell, M. & Giaccia, A. J. (2006). HIF1alpha delays premature senescence through the activation of MIF. Genes Dev 20, 3366-71. Weng, K. F., Li, M. L., Hung, C. T. & Shih, S. R. (2009). Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog 5, e1000593. Weng, T. Y., Chen, L. C., Shyu, H. W., Chen, S. H., Wang, J. R., Yu, C. K., Lei, H. Y. & Yeh, T. M. (2005). Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells. Antiviral Res 67, 31-7. Winner, M., Koong, A. C., Rendon, B. E., Zundel, W. & Mitchell, R. A. (2007). Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Res 67, 186-93. Yang, Y., Wang, H., Gong, E., Du, J., Zhao, X., McNutt, M. A., Wang, S., Zhong, Y., Gao, Z. & Zheng, J. (2009). Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People's Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study. Hum Pathol 40, 1288-95. Zachary, I. & Gliki, G. (2001). Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49, 568-81. Zhang, S., Lin, R., Zhou, Z., Wen, S., Lin, L., Chen, S., Shan, Y., Cong, Y. & Wang, S. (2006). Macrophage migration inhibitory factor interacts with HBx and inhibits its apoptotic activity. Biochem Biophys Res Commun 342, 671-9. Zinkernagel, A. S., Johnson, R. S. & Nizet, V. (2007). Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) 85, 1339-46. Zwahlen, R., Walz, A. & Rot, A. (1993). In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int Rev Exp Pathol 34 Pt B, 27-42.
|